Rhodotorula sp. With high carotenoid yield as well as fermentation product and application thereof
By discovering the red yeast strain MHT01 with high-yield carotenoids and microbial fermentation technology, combined with physical low-temperature and high-pressure homogenization method, the problem of limited production of carotenoids in red yeast was solved, and efficient and stable water-soluble carotenoid raw materials were obtained. Used in cosmetics to significantly improve skin health.
Patent Information
- Application Number
- CN202411335632.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-24
- Publication Date
- 2024-11-08
AI Technical Summary
In the prior art, red yeast produces carotenoids with limited output, and the traditional extraction methods are costly and complex in process, which limits the application of carotenoids.
A red yeast strain MHT01 with high yield of carotenoids was discovered and identified. Carotenoids were prepared through microbial fermentation technology, and the method of physical low temperature, high pressure homogenization and polyol solubilizer was used to obtain water-soluble liquid raw materials, avoiding oil and fat. and the use of organic solvents.
It improves the yield and biological activity of carotenoids, reduces production costs, provides a more stable water-soluble product, suitable for cosmetic preparation, and significantly improves the skin's moisture retention, elasticity and wrinkle reduction effects.
Smart Images

Figure CN118909806A_ABST
Abstract
Description
Technical Field
[0001] The invention discloses a red yeast with high carotenoid yield, a fermentation product and application thereof, and belongs to the technical field of microorganisms. Background Art
[0002] Carotenoids are an important natural green antioxidant and colorant, which are widely used in food nutrition, feed additives, biomedicine, daily chemicals and other industries. The traditional method of obtaining carotenoids is to extract carotenoids from natural organisms, such as tomatoes, shrimps and crabs. The traditional method has high extraction cost, complex process and high price, which strictly limits the practicality of carotenoids. Seeking new and more economical preparation methods is a major demand hotspot. Microorganisms have been the cell factories that scientists have focused on since the 21st century. They have the advantages of easy regulation, short cycle, high production capacity and sustainable production. According to statistics, microorganisms that can produce carotenoids include red yeast, Blakeslea trispora, algae, etc. Among them, red yeast has the advantages of low nutritional requirements, short growth cycle, easier process control and the ability to achieve industrial mass production. With the rapid development of social science and technology, some chemically synthesized cosmetic raw materials are being abandoned, and people's eyes are shifting more to natural and sustainably obtained raw materials. Therefore, the preparation of carotenoids by microbial fermentation technology has great market value.
[0003] According to statistics, the production of carotenoids by red yeast is currently limited by the production of pigments, and it is urgent to screen out red yeast strains that are high in carotenoid production and economical. Summary of the invention
[0004] The purpose of the present invention is to address the deficiencies of the prior art and discover a strain of red yeast (Rhodotorula mucilaginosa) MHT01, which can produce high levels of carotenoids.
[0005] To achieve the above purpose, the specific technical solution is as follows:
[0006] The first technical solution of the present invention is to provide a high-carotenoid red yeast (Rhodotorula mucilaginosa), named MHT01, which is deposited in the General Microbiological Center of China Microbiological Culture Collection Administration, with a deposit number of CGMCC No.31295 and a deposit date of July 15, 2024.
[0007] Furthermore, the strain was collected from naturally decayed kiwifruit in Baiyun District, Guangzhou City, Guangdong Province.
[0008] Furthermore, the strain was classified and identified through microbial oil immersion microscopy, morphological observation and ITS sequence sequencing.
[0009] Further, the microscopic examination of the strain is shown in the attachedFigure 1 The colony morphology is shown in the attached figure. Figure 2 As shown, the ITS characteristic sequence of the strain is shown as SEQ ID 1.
[0010] The second technical solution of the present invention is to provide a red yeast fermentation product.
[0011] To achieve the above purpose, the specific technical solution is as follows:
[0012] Step 1: streak red yeast on a yeast extract peptone glucose solid plate for three generations to obtain a monoclonal strain;
[0013] Step 2: Pick a monoclonal red yeast and shake it in a sterile yeast extract powder peptone glucose liquid medium, and culture it in a shaking table at 30° C. and 200 rpm for 2 days to obtain a first-level seed liquid of red yeast;
[0014] Step 3, inoculate the red yeast seed liquid into the fermentation medium, the inoculation amount is 1%, and culture in a shaking table at 30°C and 200 rpm for 2 days;
[0015] Step 4: After fermentation, the fermentation product was centrifuged at 12000 rpm for 10 min, the supernatant was discarded, and the bacteria were collected.
[0016] Step 5. Resuspend the bacteria with sterile saline and repeat step 4. Wash the bacteria three times.
[0017] Step 6: Take sterile pure water with half the volume of the fermentation medium, add 0.3% di-tert-butyl hydroxyhydrocinnamic acid and 0.1% tocopherol, resuspend the bacteria, precool the low-temperature microfluidizer to 4-8°C, set the pressure to 2000psi, and homogenize for 40 minutes.
[0018] Step 7: Centrifuge at 12000 rpm for 10 min to collect the supernatant.
[0019] Step 8: The supernatant was microfiltered through a 0.45 μm membrane.
[0020] Step nine, adding 30% 1,3-butanediol, 1% hexanediol, and 0.5% p-hydroxyacetophenone to the supernatant.
[0021] The third technical solution provided by the present invention is characterized in that the fermentation product is used in the preparation of cosmetics, and the cosmetics are skin external preparations prepared with the fermentation product as an active ingredient and conventional pharmaceutical or cosmetic excipients or auxiliary ingredients.
[0022] Furthermore, the cosmetics include one or more of lotions, creams, cleansers, essences, facial masks, and mud masks.
[0023] Furthermore, the added amount of the fermentation product in the cosmetic is 0.1%-20%.
[0024] Compared with the prior art, the present invention has the following advantages and beneficial effects:
[0025] 1. The red yeast provided by the present invention can produce 305.13 μg / g of carotenoids. The new strain Y4 of red yeast (Rhodotorula mucilaginosa) screened from the park mud sample in the reference document CN108531408B has a carotenoid yield of only 58.82 mg / L. The biomass of red yeast JS2018 in the reference document CN110241033B is 51.5 g / L. The biomass of the red yeast provided by the present invention can reach 87.14 g / L after 2 days of cultivation. Therefore, the red yeast provided by the present invention has higher activity, more vigorous carotenoid metabolic branch, and greater potential and value for industrial production.
[0026] 2. The red yeast lysate provided by the present invention is different from the lysate prepared by other microorganisms on the market. The lysates on the market, such as bifid yeast lysate and lactobacillus lysate, do not contain directly detectable characteristic active ingredients, and usually only general substances such as total free amino acids, free polypeptides, and polysaccharides can be measured. In addition to the above substances, the red yeast lysate provided by the present invention also contains 53.18 mg / L of carotenoids that can be clearly detected, and has a characteristic appearance of orange-pink, which can more intuitively empower the characteristics and claims of the product. In addition, carotenoids are fat-soluble components, and carotenoids on the market often appear in the form of oil-soluble raw materials or solid powders. However, in reality, oil-soluble raw materials have great restrictions on the dosage form of the formula in product applications. Carotenoid powder is extracted from plants and algae with organic solvents, or cracked by strong acid boiling method, and carotenoids are extracted by organic solvents such as acetone, ether, and ethyl acetate. There are risks of organic solvent residues, biological carcinogenesis, and environmental pollution. The present invention does not use high-risk conditions such as oil, organic solvent, strong acid, high temperature, etc., and can obtain a water-soluble liquid raw material containing carotenoids through physical low temperature, high pressure homogenization and the addition of polyol solubilizers and antioxidants, thereby ensuring the stability and biological activity of carotenoids to a greater extent. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Attached Figure 1 This is a microscopic image of the red yeast of the present invention;
[0028] Attached Figure 2 This is a red yeast colony diagram of the present invention;
[0029] Attached Figure 3 The PCR electrophoresis diagram of the present invention;
[0030] Attached Figure 4 This is a test result diagram of the transepidermal water loss rate of the skin according to the present invention;
[0031] Attached Figure 5 This is a test result diagram of the skin elasticity index R2 value of the outer corner of the eye according to the present invention;
[0032] Attached Figure 6 This is a wrinkle change diagram according to the present invention.
[0033] The following is a further detailed description of the claims of the present invention in conjunction with the specific implementation methods, but does not constitute any limitation to the present invention. Any limited modifications made by anyone within the scope of protection of the claims of the present invention are still within the scope of protection of the claims of the present invention. DETAILED DESCRIPTION
[0034] The following is a further detailed description of the claims of the present invention in conjunction with specific implementation methods, but does not constitute any limitation to the present invention. Any limited modifications made by anyone within the scope of protection of the claims of the present invention are still within the scope of protection of the claims of the present invention.
[0035] Example 1, screening of red yeast
[0036] Use a sterile sampling swab to pick up about 0.5 cm3 of pulp from naturally rotten kiwifruit pulp, place it in 5 mL of sterile physiological saline, dilute it 10 times in sequence with sterile saline, take 10-3, 10-4, 10-5, and 10-6 and spread them in sequence on a yeast extract peptone glucose solid plate containing 0.1 g / L chloramphenicol, culture it at 30°C for 2 days, pick up red colonies for microscopic examination, streak the elliptical strains with nuclei under microscopic examination on the culture medium three times, and then preserve them with glycerol at a final concentration of 20%. A total of 14 strains were preserved.
[0037] Example 2: Screening of highly active strains that produce high levels of carotene
[0038] Inoculate 14 strains of bacteria in a 250mL conical flask containing 50mL of liquid yeast extract peptone glucose medium, culture at 30℃ and 200rpm for 2 days. After the culture is completed, take 20ml of bacterial solution, centrifuge at 12000rpm for 10min, pour out the supernatant, add sterile distilled water to wash, and then centrifuge at 12000 for 10min. Repeat the washing for 3 times, pour out the supernatant, and dry at 45℃ to constant weight to obtain dry bacteria (unit g / L). Take the same weight of dry bacteria and put it into a test tube, add 3mol / L hydrochloric acid according to the amount of 15ml / g dry bacteria, and soak for 40min. Boil in water bath for 3min, cool rapidly, centrifuge at 12000r / min for 10min to precipitate cell residues, dilute to 10mL with acetone to extract, and obtain carotenoid extract. Carotenoid content is determined as follows:
[0039] Carotenoid content (μg / g dry bacteria) = A 475nm DV / 0.16m, where:
[0040] A 475nm ——Absorbance at the maximum absorption wavelength of 475nm.
[0041] V—Total volume of organic solvent used for extraction (mL).
[0042] D—Dilution multiple of the extract.
[0043] m—mass of dry yeast (g).
[0044] 0.16—Extinction coefficient of carotenoids.
[0045] The results of the 14 preferred strains are shown in Table 1, among which the strain MHT01 had the highest cell dry weight and carotenoid production.
[0046] Table 1. Biomass and carotenoid yield
[0047] strains Carotenoid yield (μg / g) Biomass (g / L) Total carotenoid content (μg / L) MHT01 305.13 87.14 26589.03 MHT02 264.23 70.45 18615.00 MHT03 164.24 54.66 8977.36 MHT04 246.44 45.54 11222.88 MHT05 198.45 56.44 11200.52 MHT06 251.33 41.25 10367.36 MHT07 300.12 60.14 18049.22 MHT08 126.52 68.49 8665.35 MHT09 102.32 68.35 6993.57 MHT10 241.06 47.55 11462.40 MHT11 243.14 59.8 14539.77 MHT12 205.39 73.14 15022.22 MHT13 166.30 69.33 11529.58 MHT14 176.25 70.68 12457.35
[0048] Example 3: Genetic identification of high-yield strain MHT01
[0049] Pick up the colony and put it in 150ul PBS, resuspend and mix to make bacterial solution. Perform PCR amplification according to the following addition ratio. Primer sequence (5' to 3'):
[0050] ITS1 TCCGTAGGTGAACCTGCGG
[0051] ITS4 TCCTCCGCTTATTGATATGC
[0052] Table 2. PCR amplification system
[0053] System Name volume 2xTaqMasterMix 25ul ITS1 1ul ITS4 1ul Bacterial liquid 10ul ddH2O 13ul Overall system 50ul
[0054] Table 3. PCR amplification conditions
[0055]
[0056] After the PCR amplification is completed, the amplified product is subjected to 2% agarose gel electrophoresis at 120V and 400mA for 20min (the brightest marker is 750bp). The electrophoresis results are as follows: Figure 3 shown.
[0057] Recovery and sequencing
[0058] Figure 3 The PCR product was shown to be a single specific band, so the PCR product was recovered and purified, and then sequenced using primer ITS. The sequence SEQID1 is as follows:
[0059] TTCTCTATATATATATATATGTATGTATTTATCTTATCTTGGTGTCCTATCTCTCACTTTCTATCTTGTGCAC
[0060] TTGTTTTGGTATAGTATCTCTCGCTATATATCTAACTCCTATTCACTTATTACACATATTCTATGATTGTATT
[0061] AAATTTTATAACAAAATATAACTTTCAACAACGGTTCTCTTGGCTCTCGCATCGATGAAGAACGCATCGAAAT
[0062] GCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACCTTGCGCTCCATGGTATT
[0063] CCGTGGAGCATGCCTGTTTGAGTGTCATGAATACTTCAACCCTCCTCTTTCTTAATGATTGAAGAGGTGTTTG
[0064] GTTTCTGAGCGCTGCTGGCCTTTACGGTCTAGCTCGTTCGTAATGCATTAGCATCCGCAATCGAACTTCGGAT
[0065] TGACTTGGCGTAATAGACTATTCGCTGAGGAATTCTAGTCTTCGGATTATAGCCGGGTTGGGTTAAAGGAAGC
[0066] TTCTAATCAGAATGTCTACATTTTAAGATTAGATCTCAAATCAGGTAGGACTACCCGCTGAACTTAAGCATAT
[0067] CAAAA
[0068] Example 4: Preparation of red yeast lysate
[0069] The present embodiment provides a red yeast lysate, and the preparation method of the lysate includes the following steps: picking MHT01 into a 2L conical flask containing 500mL of yeast extract powder peptone glucose liquid culture medium, culturing at 30°C and 200rpm for 2 days, centrifuging at 12000rpm for 10min, collecting bacteria, resuspending the bacteria with sterile physiological saline, centrifuging again for 10min, repeatedly washing 3 times, adding 0.3% di-tert-butyl hydroxyhydrocinnamic acid and 0.1% tocopherol to 250mL of sterile pure water, and resuspending the bacteria, precooling to 4°C in advance by low-temperature microfluidization, setting the pressure to 2000psi, homogenizing for 40min, using a centrifuge at 12000rpm, centrifuging for 10min to collect the supernatant, microfiltering the supernatant through a 0.45μm membrane, and adding 30% 1,3-butanediol, 1% hexanediol, and 0.5% p-hydroxyacetophenone to the supernatant.
[0070] Example 5: Application of red yeast lysate in cosmetics
[0071] The present embodiment provides an essence, which comprises, by parts: 1 part of the red yeast lysate provided in Example 4, 2 parts of ginseng extract, 3 parts of citrus extract, 2 parts of oat extract, 2 parts of rice fermentation product filtrate, 0.5 parts of carnosine, 1 part of 1,2-hexanediol, 0.5 parts of phenoxyethanol, 3 parts of butylene glycol, 8 parts of glycerin, and 77 parts of purified water.
[0072] Example 6: Application of red yeast lysate in cosmetics
[0073] This embodiment provides an essence, which contains 5 parts of red yeast lysate provided in Example 4 and 73 parts of purified water, and other components are the same as those in Example 5.
[0074] Example 7: Application of red yeast lysate in cosmetics
[0075] This embodiment provides an essence, which contains 10 parts of red yeast lysate provided in Example 4 and 68 parts of purified water, and other components are the same as those in Example 5.
[0076] Comparative Example 1: Preparation of red yeast lysate
[0077] The present comparative example provides a red yeast lysate, and the preparation method of the lysate comprises the following steps: picking MHT01 into a 2L conical flask filled with 500mL of yeast extract powder peptone glucose liquid culture medium, culturing at 30°C and 200rpm for 2 days, centrifuging at 12000rpm for 10min, collecting bacteria, resuspending the bacteria with sterile physiological saline, centrifuging again for 10min, repeatedly washing 3 times, resuspending the bacteria with 250mL of sterile pure water, precooling to 4°C in advance by low-temperature microfluidization, setting the pressure to 2000psi, homogenizing for 40min, centrifuging at 12000rpm for 10min to collect supernatant, microfiltering the supernatant through a 0.45μm membrane, and adding 30% 1,3-butanediol, 1% hexanediol, and 0.5% p-hydroxyacetophenone to the supernatant.
[0078] Comparative Example 2: Preparation of red yeast lysate
[0079] This comparative example provides a red yeast lysate. The difference between this comparative example and Example 4 is that low-temperature microfluidization is used under normal temperature conditions, and the other aspects are the same as Example 4.
[0080] Comparative Example 3
[0081] This comparative example provides an essence liquid, which is different from Example 5 in that the red yeast lysate is replaced by purified water, and the other components are the same as those in Example 5.
[0082] Comparative Example 4
[0083] This comparative example provides an essence, which is different from Example 7 in that the red yeast lysate is the red yeast lysate provided in Comparative Example 1, and the other components are the same as those in Example 7.
[0084] Comparative Example 5
[0085] This comparative example provides an essence, which is different from Example 7 in that the red yeast lysate is the red yeast lysate provided in Comparative Example 2, and the other components are the same as those in Example 7.
[0086] In order to better illustrate the advantages of the present invention, the test experiments provided by the present invention are given below.
[0087] Experiment 1: Determination of carotenoid content of lysates in Example 4, Comparative Example 1 and Comparative Example 2
[0088] 10 mL of the red yeast lysate in Example 4, Comparative Example 1, and Comparative Example 2 was taken, vacuum freeze-dried at -70°C, and extracted with 10 mL of acetone to obtain a carotenoid extract. The carotenoid content was determined by the method in Example 2. The experimental results are shown in Table 4.
[0089] Table 4. Carotenoid content in different lysates
[0090] Group Carotenoid yield (μg / g) Example 4 310.06 Comparative Example 1 264.23 Comparative Example 2 151.88
[0091] The method for lysing red yeast provided by the present invention uses physical high pressure. Since carotenoids are very unstable, in the case of no antioxidant in Comparative Example 1, a part of carotenoids are oxidized by air, the content is reduced, and the color is observed to be slightly lighter. Secondly, since carotenoids are also extremely unstable to heat, we tested the consequences of not lysing the bacteria at low temperature in Comparative Example 2. As a result, repeated high pressure caused the lysis temperature to reach above 60°C. Finally, it was measured that the red yeast lysate in Comparative Example 2 lost more and degraded by about 50%.
[0092] Experiment 2: Test of the application formula of red yeast
[0093] Human body tests were performed on the essences described in Examples 5-7 and Comparative Examples 3-5
[0094] Anti-aging efficacy indicators: transepidermal water loss rate, skin elasticity and skin firmness.
[0095] A total of 140 female subjects aged 30 to 55 years who met the inclusion criteria were recruited and randomly divided into 7 groups, with 20 subjects in each group. The subjects were healthy female subjects with non-sensitive facial skin (passed the sensitive skin screening questionnaire), all facial skin types (including oily, mixed oily, normal, mixed dry, and dry), no large-area or long-term frequent acne, acne marks, peeling, tingling, etc. on the facial skin, and self-assessed facial skin that was rough, loose, and lacked elasticity, and the level of facial forehead wrinkles (forehead wrinkles) was ≥3 (based on Asian skin The subjects had no obvious redness, lesions or scars on the skin in the test area. The subjects were able to read and understand all the contents of the informed consent form and voluntarily signed the informed consent form.
[0096] How to use the serum
[0097] After cleansing every day, the subjects took 4 to 5 pumps on the palm, applied evenly on the face, and gently pressed for absorption.
[0098] Test Method
[0099] The temperature was controlled at (21±1)℃ and the relative humidity was 50%±5%. After the tester cleaned his face slightly, he waited for 30 minutes in this environment before the test. The transepidermal water loss rate was tested with the skin moisture tester TewameteTM300, the skin elasticity was tested with the skin elasticity tester CutometerdualMPA580, the facial image acquisition and skin texture analysis were performed with VisioscanVC20plus, the facial image acquisition and skin wrinkle analysis were performed with Primos-CR, and the facial image acquisition and skin wrinkle and skin texture analysis were performed with VISIA.
[0100] The transepidermal water loss rate, skin elasticity, skin wrinkles and other data of all subjects before using the product were used as the control group. The subjects used the test samples for 28 consecutive days according to the instructions. The transepidermal water loss rate, skin elasticity, skin wrinkles and other data of the subjects were tested before using the samples and after 28 days of use as the experimental group. (Change rate = (measured value after using the sample - measured value before using the sample) / measured value before using the sample × 100%).
[0101] Data analysis
[0102] The data were statistically analyzed using SPSS 19.0 software, and the test data were tested for normal distribution. If the test data were normally distributed, the T test method was used for statistical analysis; if the test data were non-normally distributed, the rank sum test method was used for statistical analysis. All statistical analyses were two-tailed tests, with significance * at P < 0.05, significance ** at P < 0.01, significance *** at P < 0.005, and significance **** at P < 0.001.
[0103] The skin barrier is mainly composed of the sebum membrane and the stratum corneum, which plays a key role in maintaining skin moisture and preventing the invasion of harmful substances from the outside world. When the skin barrier is damaged, the transepidermal water loss rate will increase. A healthy skin barrier can effectively lock in moisture and reduce the evaporation of water from the skin surface. If the skin barrier function is weakened, such as the thinning of the stratum corneum and the destruction of the sebum membrane, the skin's water retention capacity decreases, and moisture is more easily lost through the skin to the environment, resulting in an increase in transepidermal water loss. Conversely, an increase in transepidermal water loss may also reflect problems with the skin barrier. If the transepidermal water loss rate remains at a high level for a long time, it will further aggravate problems such as dry skin and affect the repair and stability of the skin barrier. Therefore, a good skin barrier helps to reduce the transepidermal water loss rate, and the transepidermal water loss rate can be used as an important indicator for evaluating the skin barrier function. Figure 4 This is the test result of skin transepidermal water loss rate. Figure 4It can be seen that after the subjects used the essence for 28 days, the transepidermal water loss rate of the skin showed a decreasing trend. Examples 5-7 and Comparative Examples 4 and 5 were significantly lower than the control group before using the sample at 28 days. Comparison of Example 5 with Examples 6 and 7 showed that the transepidermal water loss rate of the skin decreased more significantly with the increase in the concentration of the red yeast lysate. Comparison of Example 7, Comparative Example 4 and Comparative Example 5 showed that the efficacy of the lysate was greatly related to the preparation method, and the difference in efficacy was positively correlated with the content of carotenoids in Table 4.
[0104] As we age, our skin ages and its elasticity decreases significantly. Figure 5 The closer the test value is to 1, the better the skin elasticity. Figure 5 It can be seen that within 28 days of the test, the skin elasticity of Example 7 increased from 0.654 before use to 0.872 (p<0.01), the increase in Example 6 was slightly weaker, and there was no significant increase in Comparative Example 3 and Example 5. This shows that the red yeast lysate is positively correlated with the test concentration in anti-aging, and the anti-aging effect is not obvious when it is not added or at a low concentration. Since aging can cause the moisture content of the skin to decrease, dry skin can also cause elasticity to deteriorate. Therefore, the anti-aging test results are consistent with the skin transepidermal moisture test results.
[0105] The better the skin elasticity, the fewer wrinkles; the worse the skin elasticity, the less it can rebound well when affected by the movement of facial muscles, gravity, etc., and the more and deeper the wrinkles are. Figure 6 .exist Figure 6 The changes in wrinkles can be more clearly seen in the results. Before using the essence, the skin wrinkle value was 145.66. After using the essence for 28 days, the skin wrinkle values of each group decreased to varying degrees. The skin wrinkle value of the essence provided in Example 7 decreased to 112.04 (p<0.005). From the comparison of each group, it is not difficult to find that Example 7 has the strongest and most significant wrinkle smoothing effect. Although the active products contained in Comparative Examples 4 and 5 are lost, significant wrinkle removal effects are observed. Comparative Example 3 has no significant anti-wrinkle effect due to the lack of red yeast lysate. This fully proves that the red yeast provided by the present invention can increase skin moisture, repair skin barrier, improve skin elasticity, and thus delay skin aging, and has a good application value in cosmetics.
Claims
1. A red yeast (Rhodotorula mucilaginosa) with high carotenoid production, characterized in that: Named MHT01, it is deposited in the General Microbiology Center of China Microbiological Culture Collection Administration, with the deposit number CGMCC No.31295 and the deposit date July 15, 2024.
2. A fermentation product of red yeast with high carotenoid yield, characterized in that: The fermentation product is obtained by fermenting red yeast, and the fermentation method is liquid aerobic fermentation.
3. The fermentation product according to claim 2, characterized in that: The fermentation temperature is 30°C.
4. The fermentation product according to claim 2, characterized in that: The fermentation time is 48h.
5. The fermentation product according to claim 2, characterized in that: The fermentation product is one or more of red yeast fermentation product filtrate and red yeast lysate obtained by red yeast fermentation.
6. The fermentation product according to claim 5, characterized in that: The preparation method of the red yeast lysate comprises the following steps: culturing the red yeast, collecting the cells by centrifugation, washing the cells with sterile physiological saline, resuspending the cells with sterile pure water, adding 0.3% di-tert-butyl hydroxyhydrocinnamic acid and 0.1% tocopherol, and then lysing the cells at 4-8°C and 2000psi pressure for 40 minutes, centrifuging at 12000rpm for 10 minutes to remove cell debris, performing 0.45μm microfiltration, collecting the filtrate, and adding 30% 1,3-butanediol, 1% hexanediol, and 0.5% p-hydroxyacetophenone to obtain the yeast lysate.
7. The red yeast fermentation product filtrate according to claim 5, characterized in that: The method for preparing the red yeast fermentation product filtrate comprises the following steps: collecting the supernatant by centrifugation and membrane separation after culturing the red yeast, and adjusting the pH of the supernatant, desalting, sterilizing and compounding to obtain the red yeast fermentation product filtrate.
8. Use of the fermentation product according to any one of claims 2 to 7 in cosmetics, characterized in that: The fermentation product is used in the preparation of cosmetics, which are external skin preparations prepared by using the fermentation product as an active component and adding conventional pharmaceutical or cosmetic excipients or auxiliary ingredients.
9. The use according to claim 8, characterized in that: The cosmetics include one or more of lotions, creams, cleansers, essences, facial masks, and mud masks.
10. The use according to claim 8, characterized in that: The added amount of the fermentation product in the cosmetics is 0.1%-20%.
Citation Information
Patent Citations
Rhodotorula mucilaginosa for producing beta-caroten, beta-caroten and its production method
CN101008000A
Cosmetic composition
CN101686923A
Production of carotenoids in oleaginous yeast and fungi
CN103589650A
Rhodotorula mucilaginosa and fermentation culture substance and application thereof
CN106010990A
Rhodotorula mucilaginosa mutant strain and application thereof
CN107699502A
Cited By
Double-yeast self-assembled nano-emulsion as well as preparation method and application thereof
CN120837366A
A double-yeast self-assembled nanoemulsion, a preparation method and application thereof
CN120837366B
Rhodotorula mucilaginosa strain, fermentation product filtrate thereof and biological product thereof
CN121109164A
Gluco- red yeast strain, its fermentation product filtrate and its biological product
CN121109164B
Soothing and anti-aging composition containing crocus sativus fermentation product and preparation method of soothing and anti-aging composition
CN121243030A
